CLCS logo
OTC · CLCSBiotechnologyUpdated Nov 2, 2026

Cell Source, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Cell Source, Inc. (CLCS) is 22.48%

According to Cell Source, Inc.’s latest financial reports and current stock price. The company's current ROE is 22.48%. This represents a change of 235.24% compared to the average of 6.71% of the last 4 quarters.

Cell Source, Inc. (CLCS) Historical ROE (quarterly & annually)

How has CLCS ROE performed in the past?

The mean historical ROE of Cell Source, Inc. over the last ten years is 43.82%. The current 22.48% ROE has changed -48.69% with respect to the historical average. Over the past ten years (40 quarters), CLCS's ROE was at its highest in in the March 2019 quarter at 28.54%. The ROE was at its lowest in in the December 2016 quarter at -21.74%.

Quarterly (TTM)
Annual

Average

43.82%

Median

41.97%

Minimum

15.51%

Maximum

77.94%

Cell Source, Inc. (CLCS) ROE by Quarter and Year

Discovering the peaks and valleys of Cell Source, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 336.29%

Maximum Annual ROE = 77.94%

Minimum Annual Increase = -64.34%

Minimum Annual ROE = 15.51%

Quarterly (TTM)
Annual
YearROEChange
202520.65%-18.65%
202425.38%-25.53%
202334.08%-16.68%
202240.91%-26.54%
202155.69%-2.94%
202057.38%-26.38%
201977.94%81.13%
201843.03%-36.40%
201767.65%336.29%
201615.51%-64.34%

Cell Source, Inc. (CLCS) Average ROE

How has CLCS ROE performed in the past?

The current ROE of Cell Source, Inc. (CLCS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

26.70%

5-year avg

35.34%

10-year avg

43.82%

Cell Source, Inc. (CLCS) ROE vs. Peers

How is CLCS’s ROE compared to its peers?

Cell Source, Inc.’s ROE is less than Celularity Inc. (142.25%), greater than IN8bio, Inc. (-91.18%), greater than CytoMed Therapeutics Limited (-91.37%), greater than Xenetic Biosciences, Inc. (-40.62%), greater than Nkarta, Inc. (-39.64%), less than MiNK Therapeutics, Inc. (83.45%), less than Tevogen Bio Holdings Inc. (248.50%), greater than Cellectis S.A. (-94.14%), greater than Precision BioSciences, Inc. (-91.60%), greater than Legend Biotech Corporation (-8.70%),

Build a custom stock screener for Cell Source, Inc. (CLCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cell Source, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cell Source, Inc. (CLCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cell Source, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Cell Source, Inc.'s ROE?

How is the ROE calculated for Cell Source, Inc. (CLCS)?

What is the highest ROE for Cell Source, Inc. (CLCS)?

What is the 3-year average ROE for Cell Source, Inc. (CLCS)?

What is the 5-year average ROE for Cell Source, Inc. (CLCS)?

How does the current ROE for Cell Source, Inc. (CLCS) compare to its historical average?